Literature DB >> 23168578

Evaluating iron status and the risk of anemia in young infants using erythrocyte parameters.

Ingrid Kristin Torsvik1, Trond Markestad, Per Magne Ueland, Roy M Nilsen, Oivind Midttun, Anne-Lise Bjørke Monsen.   

Abstract

BACKGROUND: Correct evaluation of iron status is important in young infants because both iron deficiency and excess may have negative effects on development, growth, and morbidity.
METHODS: We evaluated iron status using erythrocyte parameters, including reticulocyte hemoglobin content (CHr) in infants with birth weight <3,000 g (n = 80). Blood samples and infant characteristics were recorded at 6 wk and at 4 and 6 months. Infants with a birth weight ≤2,500 g (n = 36) were recommended for iron supplementation.
RESULTS: Despite a significantly poorer status at 6 wk, iron-supplemented infants had significantly higher hemoglobin level (Hb): 12.2 (SD = 0.8) g/dl and CHr: 28.3 (SD = 1.4) pg at 6 mo, as compared with nonsupplemented infants, Hb: 11.7 (SD = 1.0) g/dl, P = 0.02 and CHr: 26.5 (SD = 2.5) pg, P < 0.001. Prolonged exclusive breastfeeding, high weight gain, and male gender were the predisposing factors for a low iron status at 6 mo. A CHr cutoff level of 26.9 pg at 4 mo proved to be a sensitive predictor for anemia at 6 mo.
CONCLUSION: Signs of an iron-restricted erythropoiesis were observed in nonsupplemented infants (birth weight 2,501-3,000 g), and CHr was a useful tool for evaluating iron status. The need for iron supplementation in certain infant risk populations should be further evaluated.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23168578     DOI: 10.1038/pr.2012.162

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  8 in total

1.  Reference intervals for reticulocyte parameters of infants during their first 90 days after birth.

Authors:  R D Christensen; E Henry; S T Bennett; H M Yaish
Journal:  J Perinatol       Date:  2015-10-29       Impact factor: 2.521

2.  Using the hemoglobin content of reticulocytes (RET-He) to evaluate anemia in patients with cancer.

Authors:  Ellinor I B Peerschke; Melissa S Pessin; Peter Maslak
Journal:  Am J Clin Pathol       Date:  2014-10       Impact factor: 2.493

3.  Reticulocyte hemoglobin equivalent as a potential marker for diagnosis of iron deficiency.

Authors:  Yasumichi Toki; Katsuya Ikuta; Yoshie Kawahara; Noriyasu Niizeki; Masayuki Kon; Motoki Enomoto; Yuko Tada; Mayumi Hatayama; Masayo Yamamoto; Satoshi Ito; Motohiro Shindo; Yoko Kikuchi; Mitsutaka Inoue; Kazuya Sato; Mikihiro Fujiya; Toshikatsu Okumura
Journal:  Int J Hematol       Date:  2017-03-15       Impact factor: 2.490

4.  A two-and-a-half-year-old breastfed toddler presenting with anemia: a case report.

Authors:  Fabian Bock; Katrin Borucki; Peter Vorwerk; Ronald Biemann; Berend Isermann
Journal:  BMC Res Notes       Date:  2014-12-16

5.  Evaluation of hemoglobin performance in the assessment of iron stores in feto-maternal pairs in a high-risk population: receiver operating characteristic curve analysis.

Authors:  José Carlos Jaime-Pérez; Gisela García-Arellano; Nereida Méndez-Ramírez; Óscar González-Llano; David Gómez-Almaguer
Journal:  Rev Bras Hematol Hemoter       Date:  2015-02-17

6.  The association between parental migration and early childhood nutrition of left-behind children in rural China.

Authors:  Huifeng Shi; Jingxu Zhang; Yufeng Du; Chunxia Zhao; Xiaona Huang; Xiaoli Wang
Journal:  BMC Public Health       Date:  2020-02-18       Impact factor: 3.295

7.  Lower iron stores were associated with suboptimal gross motor scores in infants at 3-7 months.

Authors:  Ulf Wike Ljungblad; Trine Tangeraas; Henriette Paulsen; Morten Lindberg
Journal:  Acta Paediatr       Date:  2022-07-08       Impact factor: 4.056

8.  The Importance of RET-He in the Diagnosis of Iron Deficiency and Iron Deficiency Anemia and the Evaluation of Response to Oral Iron Therapy.

Authors:  Mehmet Ali Uçar; Mesude Falay; Simten Dağdas; Funda Ceran; Selin Merih Urlu; Gülsüm Özet
Journal:  J Med Biochem       Date:  2019-01-22       Impact factor: 3.402

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.